Bortezomib + MEC (Mitoxantrone, Etoposide, Cytarabine) for Relapsed/ Refractory Acute Myeloid Leukemia: Final Results of an Expanded Phase 1 Trial
Year: 2014
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Anjali S. Advani, Paul Elson, Matt E. Kalaycio, Sudipto Mukherjee, Aaron T. Gerds, Betty K. Hamilton, Sean Hobson, Arian Smith, Mary Lynn Rush, Samjhana Bogati, Monique Biggins, Eric D. Hsi, Hien K. Duong, Edward A. Copelan, Frederic J. Reu, Yogen Saunthararajah, Aziz Nazha, Hideki Makishima, Bartlomiej Przychodzen, Brittney Dienes, Jaroslaw P. Maciejewski, Jennifer S Carew, Hetty E. Carraway, Mikkael A. Sekeres
Institutions: Cleveland Clinic, Levine Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2552062425